Pycnodysostosis: Clinical, radiologic, and endocrine evaluation and linear growth after growth hormone therapy

Metabolism: Clinical and Experimental

Volumn 50, Issue 8, 2001, Pages 905-911

  Soliman, Ashraf T ^a,b   Ramadan, Magdy A F ^a,b   Sherif, Ahmed ^a,b   Aziz Bedair, El Said M ^a,b   Rizk, Moustafa M ^a,b  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b BENHA UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CLONIDINE; GLUCAGON; GROWTH HORMONE; PHOSPHORUS; SOMATOMEDIN C;

ACROMION; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTERIOR FONTANEL; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BODY HEIGHT; BONE DENSITY; BONE DYSPLASIA; BONE MALFORMATION; CHILD; CHILD DEVELOPMENT; CLAVICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; CRANIAL SUTURE; DEMYELINATING NEUROPATHY; DRUG EFFICACY; DYSOSTOSIS; ENAMEL HYPOPLASIA; ENDOCRINE FUNCTION TEST; EXOPHTHALMOS; FRONTAL BOSSING; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH RATE; HORMONE RESISTANCE; HORMONE SUBSTITUTION; HUMAN; HYPOPLASIA; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INCIDENCE; KIDNEY DISEASE; LANGUAGE ABILITY; LIVER DYSFUNCTION; MANDIBULOFACIAL DYSOSTOSIS; MOTOR PERFORMANCE; MOUTH AND TEETH; NAIL DYSPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PYKNODYSOSTOSIS; RADIOLOGICAL PARAMETERS; SHORT STATURE; SOCIAL INTERACTION; STATISTICAL ANALYSIS;

EID: 0034877057     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.24924     Document Type: Article

References (27)

1. Pycnodysostosis. Typical and atypical features and report on 7 cases
2. The malady of Toulouse Lautree
3. Pycnodysostosis in Japan: Report of six cases and review of Japanese literature
4. Pycnodysostosis
5. Pycnodysostosis
6. Novel mutations of the cathepsin K gene in patients with pycnodysostosis and their characterization
7. Characterization of novel cathepsin K mutations in the pro and mature polypeptide regions causing pycnodysostosis
8. Determination of bone markers in pycnodysostosis: Effects of cathepsin K deficiency on bone matrix degradation
9. Pycnodysostosis
10. Pycnodysostosis: Clinical and genetic considerations
11. Insulin-like growth factors and their binding proteins
12. Insulin-like growth factors
13. Alterations in the pulsatile properties of circulating growth hormone concentrations during puberty in boys
14. Effect of testosterone on somatomedin concentrations in prepubertal boys
15. Changes in serum somatomedin and growth hormone concentrations after 3 weeks oestrogen substitution in post-menopausal women: A pilot study
16. Growth hormone secretion and plasma somatomedin C in primary hypothyroidism
17. Thyroid hormone and growth hormone interact to regulate insulin-like growth factor-I messenger ribonucleic acid and circulating levels in the rat
18. Insulin-like growth factor (IGF-I) and -II and IGF-binding proteins-1, -2 and -3 in children and adolescents with diabetes mellitus: Correlation with metabolic control and height attainment
19. Effect of insulin on hepatic production of insulin-like growth factor-binding protein-1 (IGFBP1), IGFBP-3, and IGF-I in insulin dependent diabetes
20. Prolactin and somatomedin in hypopituitary patients with "catch-up" growth following operations for craniopharyngeoma
21. Somatomedins
22. Nutritionally-induced changes in hepatic insulin-like growth factor-I (IGF-I) gene expression in rats
23. Standards for children's height at ages 2-9 years allowing for height of parents
24. Defective growth hormone (GH) secretion and improved linear growth after GH therapy in children with pycnodysostosis
25. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization
26. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas